Skip to content

Bakircay University Cigli Training and Research Hospital

Bakircay University Cigli Training and Research Hospital

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04683536
Acronym
BUCEAH
Enrollment
106
Registered
2020-12-24
Start date
2015-01-31
Completion date
2020-03-31
Last updated
2020-12-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bladder Cancer

Keywords

obturator nerve blockade, bladder cancer, non-muscle invasive bladder cancer, adductor contraction, bladder perforation

Brief summary

The aim of the study is to investigate the oncological outcomes of obturator nerve blockade in patients with lateral wall localized non-muscle invasive bladder cancer

Detailed description

Patient divided into two group.First group includes patients underwent TUR-BT under only spinal anesthesia and second group includes patients underwent TUR-BT under spinal anesthesia combined with ultrasound guided obturator nerve blockade.

Interventions

PROCEDUREObturator nerve blockade

We performed spinal anesthesia combined with ultrasound guided obturator nerve blockade according to the localization of bladder cancer in patients with lateral wall localized non-muscle invasive bladder cancer

Sponsors

Recep Tayyip Erdogan University Training and Research Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* patients with lateral wall localized non muscle invasive bladder cancer

Exclusion criteria

* history of previous TUR-BT * diagnosis of non-urothelial carcinoma * coagulopathy * history of allergic reaction to the local anesthtetic agent * presence of muscle-invasive bladder cancer * history of chemotherapy or radiotherapy before TUR-BT * precence of variant histopathology * using bipolar energy for the resection of bladder tumor * presence of concomittant upper urothelial tract urothelial carcinoma * patients with the neuromusculer disease * pregnancy * history of medication effecting immune system

Design outcomes

Primary

MeasureTime frameDescription
Oncological outcomes5 yearReccurens or progression of tumor was recorded

Secondary

MeasureTime frameDescription
Complications5 yearsComplications during surgery was recorded

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026